SCHEMBL6975262

SCHEMBL6975262

COc1cc2c(=O)c(C)cn3c4ccc(Br)cc4c(c1)c23

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3R1 P27986 2/20 0.38
PIK3CA P42336 2/20 0.38
LMNA P02545 1/20 0.37
CYP19A1 P11511 1/20 0.37
NQO2 P16083 1/20 0.37
KMT2A Q03164 3/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.36
PDK1 Q15118 1/20 0.36
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978385 0.90 CYP19A1 (0.37) PIK3R1PIK3CALMNACYP19A1NQO2
SCHEMBL6979851 0.85 LMNA (0.41) LMNAKMT2AMEN1GABRA1GABRB1
SCHEMBL6976246 0.84 ALDH1A1 (0.50) LMNATSHRALDH1A1RAB9AKDM4E
SCHEMBL6981368 0.84 LMNA (0.38) LMNAMAPTSMN1; SMN2TSPOALDH1A1
SCHEMBL6975925 0.83 PTGDR2 (0.41) LMNAKMT2AMEN1ALDH1A1MCL1
SCHEMBL6978311 0.82 L3MBTL1 (0.44) CYP19A1NQO2KMT2AMEN1MAPT
SCHEMBL6979263 0.82 LMNA (0.60) LMNAKMT2ATSHRMEN1MAPT
SCHEMBL6984498 0.81 LMNA (0.36) LMNANQO2MAPTIDO1MCL1
SCHEMBL6982438 0.80 PIK3R1 (0.39) PIK3R1PIK3CAKMT2ATSHRMAPK1
SCHEMBL6976583 0.80 LMNA (0.40) LMNAMAPTGABRA1GABRB1GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed